Web Analytics

3 Latest Announced Rounds

$1,738.89M Raised in 75 Funding Rounds in the past 7 Days - View All

Funding Round Profile


start up
France - Orsay, Île-de-France
  • 17/05/2024
  • Seed
  • $11,189,199

HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.

Related People

Frederic CAROFFFounder

Frederic CAROFF France - Boulogne-Billancourt, Île-de-France

Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.

Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.